WIZ (widely interspaced zinc finger-containing protein) is a transcriptional regulator that functions through multiple molecular mechanisms to control gene expression and chr19 architecture. Primarily, WIZ serves as a component of the G9a/GLP histone methyltransferase complex, where it targets these enzymes to specific chr19 loci via its zinc finger DNA-binding domains to mediate H3K9 methylation and transcriptional repression 1. Beyond this repressive function, WIZ also participates in DNA loop architecture by forming a complex with cohesin and CTCF at enhancers, promoters, and loop anchors, where it is required for proper transcriptional regulation and maintenance of cell identity 2. ChIP-seq analysis reveals WIZ occupancy at active promoters and CTCF-binding sites, suggesting a dual role as both repressor and activator; notably, WIZ is highly expressed in brain tissue and regulates clustered protocadherin genes essential for neuronal development 3. Clinically, WIZ has emerged as a therapeutic target in sickle cell disease: molecular glue degraders that recruit WIZ to cereblon for proteasomal degradation robustly induce fetal hemoglobin expression in erythroid cells and show therapeutic efficacy in preclinical models 45. Additionally, WIZ mutations correlate with prognosis in oral squamous cell carcinoma, suggesting potential disease relevance beyond hemoglobinopathies 6.